Prot #D4981C00001: A Phase 1b/2, Open-label Study to Evaluate the Safety and Tolerability of MEDI6469 in Combination with Immune Therapeutic Agents or Therapeutic Monoclonal Antibodies in Subjects with Selected Advanced Solid Tumors or Aggressive B-cell L

Project: Research project

Project Details

StatusFinished
Effective start/end date10/22/14 → 10/22/17

Funding

  • PRA Health Sciences (Prot #D4981C00001 // Prot #D4981C00001)
  • MedImmune, LLC (Prot #D4981C00001 // Prot #D4981C00001)